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Abstract. Photoacoustic tomography is a hybrid modal-
ity based on optical absorption excitation and ultrasonic
detection. It is sensitive to melanin, one of the primary
absorbers in skin. For cells that do not naturally contain
melanin, melanin production can be induced by introduc-
ing the gene for tyrosinase, the primary enzyme responsible
for expression of melanin in melanogenic cells. Optical res-
olution photoacoustic microscopy was used in the ex vivo
study reported here, where the signal from transfected cells
increased bymore than 10 times over wild-type cells. A sub-
sequent in vivo experiment was conducted to demonstrate
the capability of photoacoustic microscopy to spectrally dif-
ferentiate between tyrosinase-catalyzed melanin and vari-
ous other absorbers in tissue. C©2011 Society of Photo-Optical Instru-
mentation Engineers (SPIE). [DOI: 10.1117/1.3606568]
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1 Introduction
Photoacoustic tomography (PAT) is a hybrid imaging modal-
ity which combines optical absorption excitation and ultrasonic
detection.1 Incident light is absorbed locally and converted to
heat; this conversion results in local thermoelastic expansion,
which propagates as an ultrasonic wave. PAT typically uses
wavelengths in the visible range, which are nonionizing and
safe at the energies used. It is also highly scalable and capa-
ble of imaging from microvasculature to deep structures like
sentinel lymph nodes at high resolutions using different system
implementations.2 PAT signal amplitude is proportional to the
local fluence and the absorption coefficient of the target. There-
fore, taking measurements at multiple wavelengths allows for
spectral separation of signals from different absorbers based on
their characteristic absorption spectra, enabling functional and
molecular imaging.
Reporter genes are able to create contrast for PAT. Examples
of genes or gene products for this purpose include fluorescent
proteins, LacZ, and the tyrosinase gene (TYR).3–7 Each of these
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approaches was performed in nonmammalian cells, required in-
jection of an exogenous agent, or has not been demonstrated
in vivo, respectively. For many genes of interest, expression
typically leads to a product which has little contrast for many
imaging modalities, including PAT. Reporter genes can be used
in several ways to alleviate this problem. For example, a gene
known to produce a high contrast end product can be linked to
the target gene and expressed concurrently under the same pro-
moter and, therefore, under the same conditions.8 The result is a
genetic end-product which is localized within cells or tissues in
the same region as the target. In a different strategy, a reporter
gene construct driven by a specific promoter, but lacking the
target gene, can be introduced into a cell. The promoter can
be chosen so that the reporter gene is expressed only in spe-
cific tissues. This strategy can be useful for increasing contrast
in individual tissue types, such as cancerous tumors.9 Several
imaging modalities, including optical techniques, positron emis-
sion tomography, and magnetic resonance imaging, have taken
this approach to image cellular mechanisms from cells to whole
body level.10–13 Molecular imaging is also becoming increas-
ingly important as a tool to measure dynamic cellular processes
without the need for fixing or staining a sample.9
We have developed a new contrast agent for PAT based on
the genetic expression of melanin. Melanin is one of the primary
absorbers in skin and has a broad absorption spectrum.14, 15 In
melanogenic tissues such as melanocytes, tyrosinase is the pri-
mary enzyme responsible for melanin production, and its intro-
duction into nonmelanogenic cells has been shown to result in
pigmentation.16 It is known that melanin provides strong absorp-
tion contrast for PAT.1 We therefore propose the use of TYR as a
reporter gene yielding melanin contrast for PAT in vivo. Human
embryonic kidney cells (HEK293) were transiently transfected
with the construct pReceiver-M02-CMV-C0301 (Genecopoeia,
Catalog #EX-C0301-M02), which contains the tyrosinase gene
driven by a cytomegalovirus promoter, a continuously “on”
promoter. HEK293 cells were chosen for their high transfec-
tion efficiency. The construct is shown in Fig. 1(a). Cells were
transfected using Lipofectamine Reagent (Invitrogen, Catalog
#11668–019) Levels of tyrosinase expression were quantified by
quantitative polymerase chain reaction (qPCR), and HEK293-
TYR cells were found to overexpress the tyrosinase gene by
160-fold compared to mock-transfected HEK293 cells. In addi-
tion to confirming tyrosinase expression by qPCR, an expression
of melanin could be clearly seen in the darkly pigmented cell
pellets shown in Fig. 1(b).
PAT has been developed into two main system types: raster
scan-based photoacoustic microscopy and reconstruction-based
photoacoustic computed tomography.2 The system used here is
the optical-resolution photoacoustic microscope (OR-PAM),17
shown in Fig. 2. For this system, the resolution is defined by the
tight illumination focus, with relatively loosely focused ultra-
sonic detection. The illumination pulse, provided by a Nd:YLF
(Edgewave) pumped dye laser (Sirah), is filtered through a pin-
hole and focused onto the sample via a 0.2 NA microscope
objective lens. Two prisms separated by a silicone oil layer di-
vert the generated ultrasonic waves in order to achieve confocal
illumination and acoustic detection. The ultrasonic waves are
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Fig. 1 (a) pReceiver-M02 cassette with tyrosinase gene used for trans-
fection showing cytomegalovirus (CMV) promoter, TYR gene, origin
of replication (Ori), antibiotic resistance (Neomycin/Amp) and simian
virus polyadenylation sequence (SV40 poly A). (b) Photograph of
melanin production in wild-type (293-wt), and tyrosinase transfected
(293-TYR) cells.
focused with a 0.46 NA planoconcave acoustic lens and de-
tected by a 75 MHz ultrasonic transducer (V2022 BC, Olympus
NDT). The signal is then pre-amplified, digitized, and trans-
ferred to a computer. The sample is raster scanned to produce
a three-dimensional image. Fluctuations in the pulse energy are
compensated for with a concurrent photodiode reading. The sys-
tem resolution in the lateral direction is about 2.6 μm, while the
axial resolution is calculated to be around 15 μm.18
Two experiments were performed, an ex vivo study to char-
acterize the signal from tyrosinase-catalyzed melanin, and an
in vivo experiment to show the capability to spectrally separate
melanin from blood. The phantom was constructed by filling
short sections of 0.3 mm i.d. Silastic R© laboratory tubing with the
different samples. As shown in Fig. 3(a), four tubes were placed
in parallel with the first tube containing lysed oxygenated blood,
the second B16 melanoma for comparison, the third wild-type
HEK293 cells, and the last tube containing the HEK293-TYR
cells. Using approximately 100 nJ incident energy, the tubes
were then imaged at three laser wavelengths: 584, 590, and
600 nm. Figure 3(b) shows the signal-to-noise-ratio (SNR) for
each of the different tubes. As seen in Fig. 3(c), the signal for
the tyrosinase transfected cells is 2 to 12 times greater than
that of blood as the wavelength increases, whereas the signal
from the wild-type cells is close to zero at all wavelengths
(not plotted). Within the range of wavelengths studied, absorp-
tion by blood decreases sharply with increasing wavelength,
while absorption by melanin decreases much more slowly. This
spectral difference is enough to separate blood absorption from
that of melanin. The calculated noise equivalent concentration
(NEC) was derived by dividing the assumed blood concentration
(150 g/l) by the SNR of the signal from the tube filled with
blood. The NEC was calculated to be around 0.4 mm for 584 and
590 nm, and 3 mm for 600 nm. The concentration of melanin was
calculated using experimental results by Siegrist and Eberle. for
the amount of melanin per 10,000 cells.19 The estimated NEC
Fig. 2 System diagram of optical resolution photoacoustic micro-
scope.
Fig. 3 (a) Photograph and normalized photoacoustic results of tube
phantom showing blood in red and melanin in green, (b) SNR from
each sample in the image, (c) SNR normalized to blood as a function
of wavelength, (d) estimated NEC of blood and melanin. Mel: melanin.
*: Estimate based on literature (Ref. 19).
for melanin was around 13 mm for all wavelengths. Figure 3(d)
shows the NEC for melanin varies widely, due to the varying
expression levels in the cells, with some cells producing more
melanin than others. The blood sample used was lysed and
homogenized, which may have resulted in a smaller standard
deviation. The NEC is a rough estimate of the system sensitiv-
ity based on melanin and hemoglobin concentrations found in
literature. Future quantitative studies will take further steps to
purify and quantify the average production of melanin in these
cells. The ex vivo results show tyrosinase-catalyzed melanin is
a good candidate for in vivo imaging, increasing the signal from
normally nonmelanogenic cells by more than 10 times over
wild-type cells.
In order to test the efficacy of using tyrosinase in vivo, trans-
fected cells were xenografted into a nude mouse ear and imaged
using the same three wavelengths as in the phantom study. To
prepare the animal, HEK293 cells were first transfected, then
pelleted and resuspended in phosphate buffer solution. Around
1×106 cells in 15 μl were then implanted subcutaneously near
the center of a nude mouse ear, which quickly caused inflamma-
tion. A 4 mm2 square area was imaged one day post-inoculation
around the injection region at two depths to maintain as much
of the inflamed region in focus as possible. Due to the transient
transfection, expression of tyrosinase, and therefore melanin,
drops within a few days. Imaging at three wavelengths allowed
for the spectral unmixing of the three primary absorbers in the
mouse ear: oxyhemoglobin, deoxyhemoglobin, and melanin.
Spectral unmixing was accomplished using the least squares
method for three absorbers.20 Although in the phantom study
only oxygenated blood was used to compare with melanin,
the known extinction coefficients for oxyhemoglobin, deoxyhe-
moglobin, and melanin are very different for these wavelengths,
with the coefficients dropping by 91, 57, and 7%, respectively,
with increasing wavelength.21, 22 It is important to note that this
algorithm can be susceptible to misclassification of absorbers
where the SNR is low or pixel-by-pixel co-registration is imper-
fect, for example, at the borders of the vessels or melanin cells.
Figure 4 shows the maximum amplitude projection results, with
(a) showing control oxygen saturation (sO2) in the vessels of
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Fig. 4 (a) Control sO2 mapping, (b) normalized control total
hemoglobin concentration, (c) sO2 mapping post-injection, (d) nor-
malized total hemoglobin and melanin concentrations post-injection;
inset shows a white light photograph post-injection. Mel: melanin.
the mouse ear. Figures 4(c) and 4(d) are composites of the two
imaging depths, with the vessels around the injection region
being 250 to 300 μm below the top surface of the inflamed
site. The inner region was shifted to maintain the surface of the
injection site in focus. The sO2 was calculated after spectral un-
mixing as the ratio of the oxyhemoglobin concentration to the
total hemoglobin concentration, with 100% being completely
oxygenated blood in the vessel. For the control image, Fig. 4(b)
shows the estimated total hemoglobin concentration in the ves-
sels in red. At one day post-injection, Fig. 4(c) shows the sO2 for
the same region and Fig. 4(d) shows the estimated melanin con-
centration normalized to blood concentration. The blue dashed
line indicates the area shown in the comparison photograph.
The presented results show that tyrosinase derived melanin
increases contrast enough to easily visualize normally non-
melanogenic cells both ex vivo and in vivo. Although imaging
was done using OR-PAM, this contrast agent has the potential
to be used in any PAT implementation. Expression of melanin
in cells is variable and depends on the efficiency of transfection,
with some cells producing little melanin. Despite the fact
that the extinction coefficient of melanin is lower than that
of hemoglobin for the wavelengths studied, and despite the
variable expression, there is enough melanin production in
the transfected cells to increase concentration to detectable
levels. The process of melanin production in transfected cells
is thought to be toxic;23 while this was not quantified in this
study, the effect seems to be small in this cell line. Future
work will involve photoacoustic reporter gene imaging using
different cell lines, as well as different methods to selectively
express melanin and improve transfection rates. Further work
is also needed to develop more sophisticated methods in order
to reduce misclassification artifacts.
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